Skip to main content

Table 4 By-category comparison between genotypes of proportion of cases developing CKD

From: Clinical utility of PKD2 mutation testing in a polycystic kidney disease cohort attending a specialist nephrology out-patient clinic

   Proportion % p-value
At least CKD3 Non-PKD2 48/105 46 0.15
  PKD2 8/25 32  
At least CKD4 Non-PKD2 23/105 22 0.21
  PKD2 3/25 12  
CKD5 or RRT Non-PKD2 14/105 13 0.04
  PKD2 0/25 0